Holen Sie sich die Stockscreener-App
433.33
5.46%
22.42
Handel nachbörslich:
433.70
0.37
+0.09%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$410.91
Offen:
$416.29
24-Stunden-Volumen:
16.83M
Relative Volume:
1.61
Marktkapitalisierung:
$541.91B
Einnahmen:
$21.68B
Nettoeinkommen (Verlust:
$6.71B
KGV:
81.79
EPS:
5.298
Netto-Cashflow:
$6.00B
1W Leistung:
+16.70%
1M Leistung:
+36.19%
6M Leistung:
+153.14%
1J Leistung:
+345.17%
1-Tages-Spanne:
$414.01
$438.50
1-Wochen-Bereich:
$361.41
$438.50
52-Wochen-Spanne:
$90.73
$438.50
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
433.33 | 474.08B | 21.68B | 6.71B | 6.00B | 5.298 |
ASML
Asml Holding Nv
|
1,989.44 | 691.68B | 39.08B | 11.61B | 9.94B | 30.00 |
AMAT
Applied Materials Inc
|
723.00 | 497.69B | 29.02B | 8.51B | 5.34B | 10.64 |
KLAC
Kla Corp
|
301.71 | 324.79B | 13.09B | 4.67B | 4.01B | 35.37 |
TER
Teradyne Inc
|
483.84 | 68.39B | 3.79B | 854.06M | 553.18M | 5.4031 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
Why is Lam Research stock surging today? - Investing.com
Lam Research Corp Stock (LRCX) Moved Up by 4.98% on Jun 30: What Signal Does It Send? - TradingKey
Is Axcelis Stock a Buy After Doubling This Year? - The Motley Fool
Why is Lam Research stock rallying today? By Investing.com - Investing.com Nigeria
Lam Research Corp. stock outperforms competitors on strong trading day - MSN
Applied Materials and Lam Research lead chip equipment rebound on AI memory demand; Super Micro tumbles 8% on Taiwan raids, SOXX +4.1% - StartupHub.ai
Lam Research (NASDAQ:LRCX) Shares Up 8.4%Should You Buy? - MarketBeat
Lam Research Corp (LRCX) Stock Up 8.4% but GF Value Says Overval - GuruFocus
Lam Research (NASDAQ:LRCX) Sets New 1-Year HighTime to Buy? - MarketBeat
Lam Research stock hits all-time high at $409.8 USD - Investing.com
Lam Research stock hits all-time high at $409.8 USD By Investing.com - Investing.com India
Lam Research Corp Stock (LRCX) Moved Up by 6.62% on Jun 29: Drivers Behind the Movement - TradingKey
Lam Research Is Maintained at Overweight by Cantor Fitzgerald - Moomoo
Susquehanna Adjusts Price Target on Lam Research to $475 From $385, Maintains Positive Rating - Moomoo
Cantor Fitzgerald raises Lam Research stock price target on share gains - Investing.com
Lam Research (LRCX): BofA Raises Its Target by $150 as Chip Equipment Spending Heads Toward $250 Billion - Insider Monkey
Why is Lam Research stock climbing today? - Investing.com UK
Why is Lam Research stock climbing today? By Investing.com - Investing.com South Africa
Lam Research (LRCX): Citi Raises Target by $135 on a Multi-Year Chip Manufacturing Investment Boom - Insider Monkey
Portus Wealth Advisors LLC Decreases Position in Lam Research Corporation $LRCX - MarketBeat
China foundries pose no immediate threat to Samsung, TSMC, Lam founder says - The Korea Economic Daily Global Edition
BofA Raises PT on Lam Research (LRCX), Keeps a Buy Rating - Insider Monkey
Barclays Maintained an “Overweight” rating on Lam Research Corporation (LRCX) - Insider Monkey
Lam Research Corp (Derivatives) to Chinese Yuan Price Today | Live LRCX to CNY Converter & Exchange Rate - CryptoRank
Kestra Private Wealth Services LLC Has $5.44 Million Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp (Derivatives) Exchanges LRCX Markets | Buy & Sell & Trade - CryptoRank
Lam Research Corp (LRCX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lam Research Corp (Derivatives) Price History and Historical Data - CoinMarketCap
Lam Research Corp (LRCX) Stock Down 5.7% but Still Overvalued -- GF Score: 85/100 - GuruFocus
Lam Research Corp Stock (LRCX) Moved Down by 4.38% on Jun 26: A Full Analysis - TradingKey
Lam Research Corp (NASDAQ:LRCX) Earns Caviar Cruise Screen Spot for Stellar Quality Metrics - ChartMill
Aaron Wealth Advisors LLC Decreases Holdings in Lam Research Corporation $LRCX - MarketBeat
LRCX Price History for Lam Research Corp Stock - Barchart.com
Applied Materials and Lam Research lead chip equipment surge on Micron's blowout quarter, SOXX +3.94% - StartupHub.ai
Lam Research (NASDAQ:LRCX) Trading Up 7.2%Time to Buy? - MarketBeat
Lam Research Corp Stock (LRCX) Moved Up by 4.78% on Jun 25: A Full Analysis - TradingKey
Ritholtz Wealth Management Boosts Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Acquired by Fifth Third Wealth Advisors LLC - MarketBeat
Banque Cantonale Vaudoise Has $14.81 Million Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation Thailand Depositary Receipts Repr 1 Sh Financial Statements – SET:LRCX01 - TradingView
Lam Research Corp (LRCX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nationwide Bailard Technology Fund's Lam Research Corp(LRCX) Holding History - GuruFocus
Lam Research Corp (Derivatives) to Japanese Yen Price Today | Live LRCX to JPY Converter & Exchange Rate - CryptoRank
Top After-Hours Gainers Today Beyond Micron: QCOM, AMAT, LRCX Surge - TradingView
Lam Research Corp (Derivatives) to United States Dollar Price Today | Live LRCX to USD Converter & Exchange Rate - CryptoRank
Lam Research Corp (Derivatives) to South Korean Won Price Today | Live LRCX to KRW Converter & Exchange Rate - CryptoRank
Lam Research Corp (Derivatives) to British Pound Sterling Price Today | Live LRCX to GBP Converter & Exchange Rate - CryptoRank
Historical Data for Lam Research Corp (Derivatives) in USD - CryptoRank
Wells Fargo Raises its Price Target on Lam Research (LRCX) - Insider Monkey
Assenagon Asset Management S.A. Has $452.15 Million Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp (Derivatives) Analytics: Price Dynamics, Quarterly Returns, and Annual Price Changes in USD - CryptoRank
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):